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Figure 1: Example of HX-4 uptake in lung tumour before and 
after nitroglycerin. 
 
Conclusion: Nitroglycerin causes a significant decrease in the 
hypoxic fraction and hypoxic volume of a majority of hypoxic 
non-small cell lung cancer tumours and metastatic lymph 
nodes. This promising result encourages further investigation 
of nitroglycerin as a sensitizing agent in a selected 
population. CT-based perfusion studies and lab experiments 
(data not shown) suggest this effect is mediated by an 
inhibition of mitochondrial respiration rather than a vascular 
effect. 
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Purpose or Objective: Previous in vivo experiments 
demonstrated that hypoxia and perfusion determined during 
fractionated RT are associated with local tumour control (LC) 
in human head and neck squamous cell carcinoma (hHNSCC). 
In a randomized clinical trial Nimorazole improved LC and 
survival of patients with HNSCC treated with RT. Biomarker 
studies using tumour material from this trial indicate that 
hypoxic tumours predominantly benefit from nimorazole, 
supporting a predictive value for hypoxia assessment. 
However, this has not been prospectively evaluated for 
radiochemotherapy (RCTx) which represents the current 
standard of care in locally advanced head and neck cancer. 
The hypothesis of the ongoing study is that the 
microenvironmental parameters are also predictive for 
response to hypoxic cell sensitizing with nimorazole in 
combination with RCTx. 
 
Material and Methods: We studied 8 different human HPV-
negative and -positive HNSCC in a nude mice xenograft 
model. Irradiation was performed with 30 fractions (fx) in six 
weeks combined with weekly cisplatin (3 mg/kg i. p.). 
Nimorazole (0.3 mg/g i. p.) was applied before each 
irradiation and was started with the first fx or after 10 fx. 
Effect of nimorazole was quantified as LC 120/180 days after 
irradiation. For histological evaluation tumours were excised 
unirradiated or after 10 fx with and without nimorazole. 
Using quantitative image analysis, microenvironmental 
parameter such pimonidazole hypoxic volume (pHV), relative 
vascular area (RVA) and perfused fraction of vessels (PF) 
were determined. 
 
Results: The data of the cell lines show pronounced 
heterogeneity in the effect of nimorazole on local tumour 
control after fractionated radiochemotherapy. Nimorazole 
significantly improved local tumour control in four of the 
eight tumours. In the two responder models FaDu and SAS, 
nimorazole was equally effective when given from start of 
radiochemotherapy or after 10 fx. The treatment with both, 
RCTx and the application of nimorazole and cisplatin were 
well tolerated by the animals. Furthermore, pHV was 
significantly reduced after 10 fx RCT with and without 
nimorazole in all four responder models in contrast to the 
non-responders.  
 
Conclusion: Apparently, the decrease of pHV after the first 
fractions of RCTx has potential as a predictive biomarker for 
LC for combination of RCTx with nimorazole and should 
therefore be further evaluated in experimental FMISO 
analysis and also in clinical trials using hypoxic cell 
radiosensitisation during RCTx.  
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Purpose or Objective: There is increasing interest in defining 
a functional association between miRNAs, endogenous small 
non-coding RNA molecules that negatively regulate gene 
expression, and tumor radiation response, with the aim of 
rationally designing miRNA-based strategies to increase 
patient radiosensitivity. In this study, we investigated for the 
first time the ability of miR-875-5p, a miRNA the role of 
which in human cancer has not been so far investigated, to 
enhance the radiation response of prostate cancer (PCa) 
cells. 
 
Material and Methods: The search for miR-875-5p targets 
relevant to radiation response was carried out by prediction 
algorithms and confirmed by the luciferase assay. miR-875-5p 
reconstitution by miRNA mimics in PCa cell lines (DU145 and 
PC-3) was used to elucidate its biological role. Radiation 
response in miRNA-reconstituted and control cells was 
assessed by clonogenic assay, immunofluorescence-based 
detection of nuclear γ-H2AX foci and single-cell 
electrophoresis comet assay.  
 
Results: EGFR was predicted by 6 different algorithms and 
confirmed by luciferase assay as a direct target of miR-875-
5p. Given the role of EGFR in determining tumor cell 
resistance to ionizing radiation by promoting epithelial-to-
mesenchymal transition (EMT) and enhancing DNA-dependent 
protein kinase activity and DNA damage repair, we assessed 
whether miR-875-5p reconstitution in PCa cells was able to 
counteract EGFR-mediated radio-resistance. Indeed, miRNA 
ectopic expression significantly increased the sensitivity of 
both DU145 and PC-3 cell lines to radiation, as indicated by 
the reduced clonogenic cell survival. Consistently, the 
kinetics of accumulation and repair of γ-H2AX nuclear foci 
showed that the resolution of foci was significantly slower in 
miR-875-5p reconstituted cells compared to control cells. In 
addition, when a more direct assessment of radiation-induced 
DNA damage and repair at the single cell level was performed 
by the comet assay, DNA comet tail moments were found to 
be significantly extended in miR-875-5p reconstituted cells 
compared to control cells, confirming the ability of the 
miRNA to impair DNA repair processes. Ectopic expression of 
miR-875-5p in PCa cells was also able to counteract EMT as 
indicated by changes in cell morphology, marked 
cytoskeleton architecture rearrangements, reduced migration 
ability and increased mRNA and protein levels of E-cadherin 
and β-catenin, the two most important molecular players in 
the EMT process. 
 
Conclusion: Overall, results from this study support the 
clinical interest in developing a novel therapeutic approach 
for PCa based on miR-875-5p reconstitution to increase 
response to radiotherapy.  
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Purpose or Objective: Dual inhibitors of PI3K and mTOR do 
not efficiently radiosensitize glioblastoma multiforme stem 
cells (GBM-SCs). However, p53-proficient GBM-SCs are more 
